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Abstract
Background: Sharing of data about variation and the associated phenotypes is a critical need, yet variant
information can be arbitrarily complex, making a single standard vocabulary elusive and re-formatting difficult.
Complex standards have proven too time-consuming to implement.
Results: The GEN2PHEN project addressed these difficulties by developing a comprehensive data model for
capturing biomedical observations, Observ-OM, and building the VarioML format around it. VarioML pairs a
simplified open specification for describing variants, with a toolkit for adapting the specification into one's own
research workflow. Straightforward variant data can be captured, federated, and exchanged with no overhead;
more complex data can be described, without loss of compatibility. The open specification enables push-button
submission to gene variant databases (LSDBs) e.g., the Leiden Open Variation Database, using the Cafe Variome
data publishing service, while VarioML bidirectionally transforms data between XML and web-application code
formats, opening up new possibilities for open source web applications building on shared data. A Java
implementation toolkit makes VarioML easily integrated into biomedical applications. VarioML is designed primarily
for LSDB data submission and transfer scenarios, but can also be used as a standard variation data format for JSON
and XML document databases and user interface components.
Conclusions: VarioML is a set of tools and practices improving the availability, quality, and comprehensibility of
human variation information. It enables researchers, diagnostic laboratories, and clinics to share that information
with ease, clarity, and without ambiguity.
Keywords: LSDB, Variation database curation, Data collection, Distribution
Background
The study of disease-causing and benign variations in
the human genome is progressing rapidly. Whole gen-
ome and exome sequencing continues to expand, and
improved tools for variant calling are becoming avail-
able [1-3]. Cost-effective sequencing, paired with vari-
ant discovery, promises to make early detection and
intervention accessible for the millions of individuals
with genetic diseases.
However, realizing this potential is blocked by
the problem of integrating and coordinating the steps
towards “a pipeline leading from discovery to delivery”
[4]. The GEN2PHEN project was initiated in 2008
to unify human and model organism genetic variation
databases, and remove the obstacles to translation
of variant data from laboratory to clinic to public [5].
This has involved attempting to unify the divergent data
representations of various database communities.
The focus of this effort is the locus-specific database
(LSDB) [6]. LSDBs describe the variants discovered on a
single gene, a gene family or a group of genes involved
in the similar diseases or traits. As of this writing, 4,111
LSDBs can be easily searched online [7]. LSDBs are
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curated by experts on their respective loci, and as such
are typically the best resources of gene variant informa-
tion available [8]. A comprehensive 2010 analysis of
1,188 LSDBs provides a useful overview of the domain,
providing encouraging results, such as finding only 5.4%
to be outdated [9]. However, the study also found that
only 8% provided detailed disease and phenotypic
descriptions. LSDBs also vary widely in format, diverging
to satisfy the immediate requirements of numerous use
cases, making comprehensive, global analysis of data
concerning a given variant difficult, if not impossible
[10]. LSDBs are also typically incomplete, either from a
lack of capacity on the part of the data submitters or
curators to include all pertinent data, or from the ori-
ginal data lacking key elements altogether [9,11]. It is
well recognised that the data will often be incomplete if
you ask too much of the submitters [12]. Into this situ-
ation, next-generation sequencing pipelines are rapidly
increasing the scale and complexity of data to be mana-
ged [13].
Methods
Undesigning a standard
All terms and abbreviations used are explained in the
glossary (Table 1).
We began by incorporating previous work on data
requirements [6,8,14] and data modelling activities, such
as PaGE-OM [15] and its generalization Observ-OM
[16], in the design of VarioML LSDBs specification.
VarioML was developed by an international collabor-
ation of variation experts, over a series of workshops
organised by the GEN2PHEN project. The design has
closely followed the work of Tyrelle and King [17] on
the now defunct BSVM standard, where they proposed
using semantically well-defined XML and RDF elements
for LSDB data integration. VarioML is designed to serve
the greater part of LSDB use cases directly, complement-
ing formats such as GSVML [18] and PML/DVAR [19],
the latter being an implementation of the PaGE-OM ob-
ject model [15]. The format is kept consistent with
PaGE-OM and Observ-OM by rooting XML element
definitions in the same object model. By providing a
structured data framework designed close to application
domains, VarioML complements tabular data formats
such as VCF [20,21] and MAGE-TAB [22], which are
designed for high-throughput and manual/spreadsheet-
based data handling needs.
The collaboration’s goal was to readdress these
requirements by providing simple data structure compo-
nents for developing use case specific solutions, defined
independently using high-level schema definition lan-
guages such as Schematron [23]. While it may sound
complex, this approach provides the necessary flexibility
to serve simple specifications for straightforward use
cases, while simultaneously enabling development of
more complex specifications, all the while maintaining a
common foundation of terms, logic, and tooling that
integrates both.
Ontologies: How much meaning is enough?
Reducing the inherent complexity of annotation formats
began by rooting the semantics of the VarioML standard
as deeply as possible into base ontologies that underlie
science and logic in general. This highlighted the need
for a new harmonized model for describing scientific
observations in general, providing a common language
usable across all domains. For this purpose, a new object
model, Observ-OM [16], was developed.
In Observ-OM, four basic concept classes represent all
elements of any kind of observable data: Targets, Fea-
tures, Protocols, and Observations. The value this model
represents for the variation pipeline is hard to overstate,
as it represents what is probably the maximum possible
simplification of elements common to all usable scien-
tific observations regarding variants and associated
phenotypes.
Grounded in Observ-OM, VarioML had the task of
adding only what is absolutely necessary to provide an
intuitive and ‘decision-free’ path for researchers and
clinicians: the shortest possible path from variation data
in all its current forms, to a unified representation, dis-
tributed globally. At the same time, this shortest path
had to be extensible to describe non-minimalistic data
as needed (Figure 1).
To achieve this, LOVD-based LSDBs [8,24] were used
as a content model, in addition to modelling done in
previous work [15,25], and in workshops organized by
the GEN2PHEN consortium. This modelling meets the
requirements specified previously [26,27]. The specifica-
tion aims to be minimalistic, but has room for additions
where the need arises. Despite this simplification, the
underlying base schema can be too verbose for many
use cases. Therefore it is important that the schema can
be “narrowed”, using separate validation tools for spe-
cific cases. This has been done for the Cafe Variome
pipeline [28], where separate Schematron [23] rules are
used for defining the content. Schematron was chosen
because it allows making complex assertions about the
content of XML documents, more complex than are
possible using the RelaxNG schema language [29] used
for defining the base VarioML schema, which has better
tooling support for defining initial schema elements.
Existing ontologies, such as the Human Phenotype
Ontology (HPO) [30], Sequence Ontology (SO) [31], and
Variation Ontology (VariO) [32], can be used with
VarioML. Separate SKOS (Simple Knowledge Organization
System) [33] vocabularies have been provided for elements
which do not have online definitions. The semantics of
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VarioML elements are well defined via the Observ-OM
model; content can be relatively easily transformed to RDF
representations for linked data approaches [34]. An ex-
ample XSLT application is provided for converting Cafe
Variome XML content to an RDF schema, derived using
the Pharmacogenetics ontology [35].
A leading example of a submission tool that fulfills this
standard is the Cafe Variome platform [28] for announ-
cing and advertising disease-related variations identified
by diagnostic laboratories, allowing them to be shared by
diverse third parties. This platform, when integrated with
diagnostic software, allows push-button submission of
data from tables to central databases. For these submis-
sions, the single variant is the agreed-upon central organ-
izing concept [26]. Variants should be submitted in
VarioML format, as seen in the example in Figure 2.
To date, this functionality has been built into the
Leiden Open Variation Database [24]; GenSearch [36], a
tool to detect and interpret variants in DNA sequences
obtained by capillary sequences; BC|SNPMax [37], a
Table 1 Glossary
Name Definition URL
API Application programming interface -
BSVM Pioneering early LSDB integration standard. See Tyrelle G, King GC, 2003 [15]
Café Variome Variation data publishing service http://cafevariome.org/
Extended Backus-Naur
Form
A notation that expresses the grammar of a computer
language.
http://en.wikipedia.org/wiki/Backus-Naur_Form
GEN2PHEN EU project integrating genotype and phenotype data. http://www.gen2phen.org
GSVML Genomic Sequence Variation Markup Language See Nakaya J, Kimura M, et al. 2010 [16]
HPO Human Phenotype Ontology http://www.human-phenotype-ontology.org/
Jackson Java JSON library http://wiki.fasterxml.com/JacksonHome
JAVA General programming language http://www.java.com
JAXB Java JSON library http://jaxb.java.net/
JSON Javascript Object Notation http://en.wikipedia.org/wiki/JSON
LSDB Gene variant database, Locus Specific Database -
MAGE-TAB A tab-delimited format for representing functional genomics
data.
http://www.mged.org/mage-tab
MIRIAM The MIRIAM Registry provides a set of online services for the
generation of unique and perennial identifiers, in the form of
URIs.
http://www.ebi.ac.uk/miriam/main/
MOLGENIS Software generating infrastructure (databases, APIs, GUIs)
for life science projects.
http://www.molgenis.org
Object Model An abstract representation of a domain’s concepts, data,
and relationships between these, used to design or generate
software.
-
Observ-OM A simple system to format and exchange observation data. http://www.molgenis.org/wiki/ObservStart
ORCID Open Researcher and Contributor Identification http://orcid.org/
PML/DVAR An implementation of the PaGE-OM object model. http://www.openpml.org/
RelaxNG Schema definition language for use with XML. http://relaxng.org/
RDF Resource Description Framework http://www.w3.org/RDF/
Schematron High-level schema definition language for use with XML. http://www.ascc.net/xml/resource/schematron/
Schematron2000.html
SKOS Simple Knowledge Organization System http://www.w3.org/2004/02/skos/
SO Sequence Ontology http://www.sequenceontology.org/
UML Unified Modeling Language http://en.wikipedia.org/wiki/Unified_Modeling_Language
VariO Variation Ontology http://variationontology.org/
VCF Variant Call Format http://vcftools.sourceforge.net/specs.html
XGAP XGAP is an open and flexible object model for xQTL, GWL,
GWA and mutagenesis data
http://www.xgap.org
XML eXtensible Markup Language http://www.w3.org/XML/
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data management tool for genomic research; and is cur-
rently being testing with Alamut [38].
Results
Composing the format
VarioML is composed from an underlying set of XML
elements, which reuse the same structural components.
Most of the XML elements like phenotype, consequence
and evidence_code are so-called ontology terms, which
have necessary properties for making cross references to
existing ontologies in a flexible way:
<phenotype term = "Autoimmune polyglandular
syndrome type 1" accession = "240300" source =
"omim"/>
All ontology terms can be annotated with comments
and database cross-references (see Figure 1). Elements can
be extended by adding new schema elements: Phenotype
is an example of an observation element which reuse
properties from the ontology term element. Observation
elements have additional information related to the obser-
vation, such as date and evidence codes For example,
an observed “consequence of mutation” has the evidence
code “curator inference,” as defined in the Evidence Code
ontology [39]:
<consequence term = "translational frameshift"
accession = "SO:0001210" source = "obo.so">
<evidence_code term = "curator inference"
accession="ECO:0000205" source="obo.eco"/>
</consequence>
Figure 1 Simplified conceptual UML object model used in VarioML. The VarioML object model is derived from Observ-OM (http://www.observ-
om.org/wiki/ObservStart), with some modifications to simplify implementation. E.g., Observable Feature (such as phenotype or mutation name) and
Observed Value (existence of phenotype or variation) are denormalized into a single XML element. This avoids unnecessary nesting of observation
elements which do often have one-to-one relationship, in the XML implementation. Entities are composed into Observations, having properties such
as evidence codes, observation protocols and observation time. Associations between elements are described as single lines, where an asterisk means a
0-to-many multiplicity relationship; i.e. Observation can have one or many evidence codes. All entities also inherit from Annotatable properties which
are needed for database cross references and comments. In this case, the open arrow symbol means inheritance or an is-a relationship.
Figure 2 A Cafe Variome submission of a COL1A1 variant. The
different VarioML elements of the data submitted are flanked by the
corresponding XML tags and explained in the text.
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Pathogenicity, on the other hand, is a special case of
consequence element, having an optional scope attribute
for indicating if the variant has been observed in an indi-
vidual, family, or population. The pathogenicity element
also has an optional phenotype element for specifying
causal relationships explicitly, where needed:
<pathogenicity term = "probably pathogenic"
uri = "http://purl.org/varioml/pathogenicity/skos/
1.0#p_0003"
scope = "family" >
<phenotype term = "Osteogenesis Imperfecta, Type I"
accession="166200" source="omim"/>
<evidence_code term = "curator inference"
accession="ECO:0000205" source="obo.eco"/>
</pathogenicity>
VarioML is currently used as the XML data submis-
sion and release format for the Cafe Variome announce-
ment service. An example of this implementation is
given in Figure 2.
In the next section, we provide a brief overview of the
elements seen in Figure 2, an example of the straightfor-
ward variant descriptions that make up the bulk of
LSDB submissions.
Modular elements for variant annotation
To match raw variation data to the standard descriptions
specified in ‘Guidelines for establishing locus specific data-
bases’ [26], users simply match their data to VarioML
elements. For large data sets, VarioML’s validation tools can
be used to check converted data. Following is a partial list
of variant data elements required and validated by Var-
ioML, some of which are used in Figure 2.
Source
The source element stores information on the submitting
sources, with attributes for submitting instance or data-
base, contact details, and acknowledgements.
VarioML requires submitter identification using the
db_xref element, and recommends that an ORCID ID
[40] be obtained for this purpose. ORCID (Open Re-
searcher and Contributor Identification) is a platform
building towards automation of authorization and access
infrastructure for institutions and federations [41]. This
combination of standardization of data and researcher
ID are necessary components of a translational informa-
tion system, in which data discovery, access, and incen-
tives to sharing must be closely integrated, constituting a
sustainable ecosystem [42].
Variant
The variant element can be used in a straightforward
manner, bounding information reported on a variant
described using the HGVS naming scheme [43], which
has recently been formally described as a scientific sub-
language in Extended Backus-Naur Form [44].
Variant also provides recursive sub-elements, for cases
where the reporting variant is composed of other var-
iants located on the same or a sister chromosome.
Variant has an optional observation target attribute.
For simplicity, the Panel element is used as a generic
target for variant: panel can be used to describe any
number of individuals, with or without group-specific
identifiers, such as family or population.
Gene
The Gene is given as a database cross-reference, where
source indicates the database or system (e.g. HUGO),
and 'accession' is the gene name (e.g., AGA). HGNC
symbols or IDs [45] must be used for the primary name
of a gene. Gene is a database cross-reference type, which
is conceptually similar to ontology term.
When specifying sources, the MIRIAM namespace
identifiers should be used [46]. For example, the identi-
fier for HGNC gene symbols is hgnc.symbol:
<gene source = "hgnc.symbol" accession = "COL1A1"/>
Use of database identifiers specified in the MIRIAM
registry insures consistent naming of sources [47].
Examples of MIRIAM in use are given in Figures 2–3.
Reference sequence
Variants must always be submitted in the context of a
reference sequence. LRGs are the preferred form for
reference sequences [48]. LRG sequences ‘provide a
stable genomic DNA framework for reporting variations
with a permanent ID and core content that never
changes’ [49].
Figure 3 VarioML elements extending the core schema. The
VarioML elements describing the effect of an AIRE variant at the
transcript and protein levels are flanked by the corresponding XML
tags and explained in the text.
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HGVS name
The name element gives the variant name. While name
has an optional attribute scheme for indicating the nam-
ing scheme used, the primary name of a variant must be
given using the HGVS naming scheme [43,44]. To allow
machine-processing, the “>” character in an HGVS name
must be encoded to “&gt;”, as defined in the XML speci-
fication [50].
Pathogenicity
Pathogenicity has values such as: No known pathogenicity,
Probably not pathogenic, Unknown, Probably pathogenic,
and Pathogenic. These values meet the guidelines for
reporting unclassified variants established in 2007 [51].
These and alternative terms are provided in a separate
SKOS vocabulary [52].
Genetic origin
The genetic origin of a variation can be given in its
own observation element. The vocabulary defined in the
VarioML SKOS vocabulary can be used [53].
Location
A variant can have multiple locations defined on differ-
ent reference sequences. The location element provides
precise standardized positioning of variants, giving pos-
sibility to integrate data easily with DAS services [54]
and genome browsers. In Figure 2, the variant position
is given using chromosomal coordinates.
Sharing policy
The inclusion of the sharing policy element in VarioML
allows setting fine-grained access control policies per in-
dividual variant. Possible values are closedAccess, embar-
goedAccess, restrictedAccess and openAccess, which are
defined in the OpenAIRE guidelines [55]. Embargo end
date tells when data can be publicly released. Use per-
mission is an ontology term which can be used for citing
licensing terms. The vocabulary describing these policies
is taken from the OpenAIRE specification [56].
Additional XML elements
Additional elements, shown in Figure 3, demonstrate a
first tier of extensions of the core specification. The fol-
lowing elements are not yet implemented in applica-
tions, and may be redefined and modified later
according to community needs.
Effects on RNA and AA sequences
Effects on gene products can be given under the
seq_changes observation element, which can store infor-
mation on RNA and AA sequences in a recursive man-
ner, using nested seq_changes elements. For example, a
top-level variant element specifies a unique position on
the genome, which can contain RNA level variants in a
seq_changes sub-element, which in turn can contain cor-
responding AA changes in a further nested seq_changes
sub-element. Consequence annotations can be assigned
on these different levels, representing expert agreement
about which level is causative of a given consequence.
The Variant element also has places for aliases and
haplotype sets. Aliases are for legacy annotations and
variations which have been named using different refer-
ence sequences. Haplotypes are sets of variants which
are in cis relative to one another. These elements can be
used if the main variant represents a larger sequence re-
gion containing multiple variations. Implementation of
these extensions will be finalised as more experience is
gained in handling such variations.
Frequency
Variants can have one or more frequency elements,
each of which can use one of three formats: decimal
number, number of cases, or categorized value. The
decimal number type gives frequency as a floating point
value; number of cases type gives frequency as a count;
and the categorized value gives frequency as an ontol-
ogy term, for categorized observations such as “exists”
or “less than 100”. Population, evidence ontology term,
evidence code, protocol id and comment attributes pro-
vide context for the frequency value.
Implementation
XML remains the reference platform of choice, provid-
ing a mature specification, and advanced tools such as
schema definition languages [57]. Our use of extensible
XML elements encourages implementers to collaborate
closely, since extending the format requires formulating
a common development strategy. However, we realized
that, as the XML schema is extended, a lacuna could
easily open between the data model and its implementa-
tions. Adapting changing XML schema into applications
has tended to be laborious. We reasoned that absolving
application developers of the need to reinvent the wheel
of data translation across formats was fundamental to
easing the effort and cost of adopting the VarioML
standard. We further reasoned that, in biomedicine as
well as in other scientific domains, the era of big data
likely makes it no longer feasible to develop formats sep-
arately from the tooling that transports them bidirec-
tionally across the required data languages (recalling the
computer science maxim, ‘Data = code’ [58] [59]).
In practice, this meant that VarioML schema elements
have to work transparently as XML, JSON, and possibly
in future as RDF, without incurring a cost of translation
to the implementer or user. Providing support for bidir-
ectional translation to JSON was a clear way in which
we could enable schema extensions to much more
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quickly and inexpensively be reflected in applications.
To this end, VarioML comes with Java and JSON APIs
(application programming interfaces), which developers
can plug into their applications to handle conversion
and publication.
JSON is the common data serialization format now
recognized as the lingua franca for data exchange over
the web (while we find no academic reference to this
fact, it is a commonplace in the web application domain.
e.g. [60]), proven to be faster and consume fewer
resources than XML [61]. Serializing to JSON facilitates
applying programming techniques to data, to create
interactive content, user interface components, etc. in
formats native to the web, simplifying the provision of
data access [62]. VarioML provides a JSON implementa-
tion, currently defined using JAXB [63] and Jackson [64]
annotations. This JSON implementation is made avail-
able as a VarioML Java library [65], which can be used to
read and write XML and JSON versions of the format.
An API is auto-generated from XML instances, provid-
ing Java object representations for all VarioML objects.
This API will be kept synchronized with the format, and
can be used as a helper tool in Java applications. A JSON
example of the source element is shown in Figure 4.
In addition to JSON support, the VarioML Java API
supports EXI, a binary compression of XML. EXI sup-
port leverages the VarioML XML schema, reducing file
sizes and the time required for data processing opera-
tions by factors of three to ten [66]. While VarioML is
primarily focused on curated variant entries produced at
the end of HTP pipelines, the use of EXI makes it
feasible to use VarioML for earlier stages of production
pipelines.
The JSON tooling provided with VarioML makes it
possible for implementers to develop dynamic user
interfaces with substantially less effort and cost [67],
expanding on the possibilities demonstrated by the ‘Web
Analysis of the Variome’ project [68,69]. A logical next
step to contribute to the end-to-end variome pipeline
would be to build a variant annotator widget, usable
with different database implementations.
Discussion
VarioML has been designed to immediately serve data
exchange needs for LSDB’s, focusing on curated variant
entries produced at the end of data production pipelines.
However, as an end-to-end variation pipeline comes to-
gether, for a common specification to be truly useful, it
must be extensible beyond the immediate LSDB use-
case. Next-generation sequencing pipelines make pos-
sible exon-capture scenarios in which tens to hundreds
of patients are sequenced in one or more genes, present-
ing new challenges in variant calling, annotation, and
data sharing [70]. To meet the holistic data integration
challenge and realize the grand variation pipeline, we
need to harmonize the data models, data standards, and
content specifications in use at each step, to encompass
the descriptive needs of all LSDBs, standardizing their
quality and accuracy, and enabling more comprehensive
and high quality data curation [26]. A number of projects
have previously attempted to fill these requirements and
provide a single multipurpose implementation format for
LSDBs, yet have come up against difficulties at multiple
levels of design and implementation [11]. Variation data
can be arbitrarily complex, making a single standard speci-
fication elusive. LSDB use cases vary a great deal in the
depth of detail and structure needed for data capture.
Complex standards have proven too time-consuming to
implement. Solutions designed in one format cannot be
readily transferred to another. Further hampering progress
towards a common specification are the multiple strong
motivations which labs have to keep variant data private
[71].
As work on a unified variome progresses, genetics re-
search faces a paradox: another attempt at a variation
standard will not be enough to surmount these obstacles.
No matter how comprehensive our current efforts, new
standards will inevitably follow. Our understanding of gen-
omic variation is rapidly evolving; multiple and often con-
flicting forms of variant annotation seem to be required to
serve differing use cases, implementations, and viewpoints.
Attempts to comprehensively integrate all such descriptions
in a single standard can, at this point, be expected to pro-
duce either unmanageable complexity, or inaccurate over-
simplification. Furthermore, looking ahead, we can be fairly
Figure 4 VarioML in JSON format. XML elements are mapped to
JSON objects using JAXB and Jackson annotations via VarioML's Java
API. Repeating XML elements become pluralised into JSON arrays.
Because JSON does not have an equivalent to XML attributes, XML
attribute names can clash with inner element names. In these cases,
the JSON name for the XML attribute is changed. Otherwise,
mapping VarioML from XML to JSON is a direct transformation of
the data structure.
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certain that new discoveries and technologies will arise that
cannot be presently designed for.
In designing VarioML, we therefore turned away from
seeking a top-down monolithic solution, choosing in-
stead to make a lightweight framework for composing
interoperable, use-case specific ‘micro-standards’ around
the generalized concepts of observation targets, ontology
terms, and observations, adapted from the Observ-OM
specification [16]. The core set of VarioML schema ele-
ments can be used as building blocks, addressing use
cases from the most minimal towards the more com-
plex, while maintaining the underlying interoperability
of the data. Implementations can use as many or as few
of these blocks as needed, and new elements can be
added into the specification as needed. However, with
this extensibility also comes the danger of the fragment-
ing specifications into incompatible versions. While ele-
ments are utilized in an increasing number of new
representations and schema, at the same time, they are
also converging all variation data into a unified variome
pipeline. Yet equalizing these needs for divergence and
convergence is a task that cannot be planned by a com-
mittee. As next generation sequencing continues acceler-
ating both the scale and complexity of the data
produced, all producers of variation data have a stake in
decreasing the gap between a general variation annota-
tion standard, and the community it serves. Accordingly,
VarioML is intended less as a ‘completed’ specification,
more as a nucleation centre around which new specifica-
tions can be developed. All variation data producers are
called upon to develop this specification collaboratively.
To this end, VarioML development has been turned
over to the community. The specification lives inside an
open collaboration framework, tightly binding new vari-
ation reporting structures to the common schema and
tooling, maintaining consistent application generation
capability and backwards compatibility with earlier
applications and data [72]. We chose two forums to
realize this collaboration framework: the VarioML forum
at the science-centered GEN2PHEN Knowledge Center
[73], where format details are discussed alongside imme-
diate access to a unified catalog of LSDBs and other
tools for variation data integration; and VarioML’s
GitHub repository [74], where the schema and XML,
JSON, Java, and RDF tools are available, in addition to
UML documentation that clarifies the relationships be-
tween specification and implementations [75]. Modified
or new compositions using schema elements must be
reported in either of these forums and discussed openly,
enabling the collaborative extension of the format with-
out breaking existing implementations.
The open-ended nature of the VarioML specification
means there should continuously be elements under ac-
tive redefinition and modification by the community.
These features should not be implemented in applica-
tions until consensus on usage is reached. For example,
the Variant element allows recursive sub-elements, for
cases where the reporting variant is composed of other
variants located on the same or a sister chromosome.
Yet this and other features (see Additional XML ele-
ments section) are not currently implemented in
applications.
Conclusions
VarioML enables researchers, diagnostic laboratories,
and clinics to improve the quality of human variation in-
formation, and to share that information with ease, clar-
ity, and without ambiguity. VarioML resolves the
inherent tendency of variation data to diverge in format
and meaning through a modular design that lives in an
open collaboration framework, composed of two linked
community forums.
With this open collaboration framework, the variome
community itself closely binds the evolution of the an-
notation format and its tooling to the science of the
study of human mutations. For example, as new config-
urations and extensions of the format are developed by
various implementers, they can be discussed and
improved at the GEN2PHEN Knowledge Center, along-
side submissions of relevant data made through Cafe
Variome. As community consensus emerges, this agree-
ment translates to changes in the schema and tooling in
the common repository. At each step, the provenance of
even small contributions are captured and can be used
as microattributions [42].
For such bottom-up, self-organizing management of a
common variation standard to work, teams working at
critical junctions in the variation pipeline must translate
a passion for the vision of the unified variome, into both
implementation and development of the shared stand-
ard. To date, VarioML has been implemented in three
applications (the Leiden Open Variation Database [24],
GenSearch [36], and BC|SNPMax [37]), and is currently
being tested in a fourth (Alamut [38]). In each case,
VarioML is used to enable push-button submission of
data through the Cafe Variome service [28].
With consensus on a minimal standard, implementa-
tion is the remaining bottleneck. Users, from research
teams to commercial software producers, need to focus
their software-related activity to those tasks in which
their resource costs are proportionally smaller than the
added value afforded by adopting new tools and data
models. VarioML has been designed to minimize the ef-
fort required for both implementation and extension,
framing the specification itself with Java and JSON APIs
on the one hand, and an open collaboration framework
on the other. We hope this approach proves useful
throughout the variation science community, as it meets
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the challenge and potential of next generation sequen-
cing, and quickens to open the path from discovery to
delivery.
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